Streetbeat News

Revenues

SPB

Spectrum Brands Holdings reported a year-over-year decline in Q4 revenue, leading to its shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 5:08 pm

ERJ

Embraer's CEO has projected a revenue growth of approximately 20% for the company in 2024. This optimistic forecast is based on the company's current business trajectory and market conditions.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 5:05 pm

DXLG

Destination XL Group, Inc. (NASDAQ:DXLG) shares dropped after reporting Q3 net sales of $119.19 million, missing analyst expectations of $120.75 million and showing an 8.1% decline. Comparable sales decreased by 6.7% Y/Y due to reduced store traffic and transaction values amid economic and inflationary pressures. The company's adjusted EPS of $0.07 met expectations, but gross margin and adjusted EBITDA fell compared to the previous year. Destination XL also lowered its full-year sales and adjusted EPS outlook, leading to a 7.90% decline in its share price to $4.32.

Portfolio Pulse from Nabaparna Bhattacharya

November 17, 2023 | 4:56 pm

DSWL

Deswell Industries, Inc. (NASDAQ:DSWL) reported H1 2024 financial results with EPS of $0.22, up from a loss of $0.04 YoY. Net sales were down 15.1% to $37.7M from $44.4M YoY. Gross margins improved in both plastic and electronic segments due to lower raw material and labor costs, and renminbi depreciation. Net income was $3.6M compared to a net loss of $0.6M in H1 2023. The company has a strong financial position with $17.4M in cash and no debt.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:17 pm

AAWH

ACRHF

CRLBF

CURLF

GTBIF

TCNNF

VRNOF

Senior analyst Pablo Zuanic from Zuanic & Associates has provided a valuation assessment of US Multi-State Operators (MSOs) in the cannabis sector, considering potential federal regulatory changes and state-level legalization trends. He uses a comprehensive methodology to calculate enterprise values (EV) for MSOs, including Acreage Holdings, Ascend Wellness, Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, and Verano. The analysis is based on factors such as share counts, net debt, and contingent liabilities. The US legal cannabis market is expected to grow significantly, from $18 million in CY20 to $40 million in CY27, indicating a positive outlook for MSOs.

Portfolio Pulse from Nicolás Jose Rodriguez

November 17, 2023 | 4:01 pm

DLTR

Dollar Tree (NASDAQ:DLTR) is evaluated against competitors in the Food & Staples Retailing industry. It has a lower P/E, P/B, and higher P/S ratios compared to the industry average, suggesting undervaluation but also potential overvaluation in sales. Dollar Tree's ROE, EBITDA, and gross profit are below the industry average, indicating possible inefficiencies, while its revenue growth outperforms the industry. The company's lower debt-to-equity ratio suggests a stronger financial position relative to its top 4 peers.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 4:00 pm

BKE

Buckle Inc (NYSE:BKE) reported Q3 FY23 sales of $303.46 million, an 8.7% decrease YOY, missing estimates of $316.70 million. Comparable store sales fell by 9.2%, and online sales dropped 16.2%. Operating expenses decreased by 3.3%, while gross profit declined by 11%, with a gross margin contraction of 120 basis points to 48.5%. Operating income decreased by 19.3%, but EPS of $1.04 beat the $0.98 estimate. Despite the sales decline, BKE shares rose by 8.65% to $37.93.

Portfolio Pulse from Shivani Kumaresan

November 17, 2023 | 3:38 pm

TAK

The European Commission has approved an expanded use of Takeda's TAKHZYRO (lanadelumab) for routine prevention of Hereditary Angioedema (HAE) in patients aged 2 years and older, making it the first long-term prophylactic HAE treatment in the EU for patients under six. The approval includes a new 150 mg strength for younger patients and is supported by clinical data from a Phase 3 study and extrapolation from an adult and adolescent study.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:26 pm

TWST

Twist Bioscience's stock is up following the release of their Q4 financial results, which surpassed expectations. Additionally, the company provided Q1 2024 revenue guidance that exceeded analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:17 pm

YTRA

Yatra Online reported a 14% year-over-year increase in Q2 sales, amounting to $11.40 million.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 2:40 pm